Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.
about
Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp.Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
P2860
Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@ast
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@en
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@nl
type
label
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@ast
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@en
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@nl
prefLabel
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@ast
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@en
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@nl
P2093
P2860
P356
P1476
Effect of rosiglitazone on HDL ...... etabolic syndrome and low HDL.
@en
P2093
Daniel J Rader
John S Millar
Katsunori Ikewaki
LeAnne T Bloedon
Megan L Wolfe
Philippe O Szapary
P2860
P304
P356
10.1194/JLR.P008136
P577
2010-10-22T00:00:00Z